NexImmune, Inc. (NEXI) Financials
NEXI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 5.9 million | 4.9 million |
| March 31, 2024 | 9.0 million | 6.0 million |
| Dec. 31, 2023 | 8.6 million | 5.1 million |
| Sept. 30, 2023 | 14.6 million | 6.3 million |
NEXI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | -2.1 million | 280542 |
| March 31, 2024 | -2.4 million | 348.3 million |
| Dec. 31, 2023 | -54.5 million | 614154 |
| Sept. 30, 2023 | -7.3 million | 1.1 million |
NEXI Net Income
No data available :(
NEXI Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 2.4 million | - | - |
| March 31, 2024 | 4.5 million | - | - |
| Dec. 31, 2023 | 4.6 million | - | 68809 |
| Sept. 30, 2023 | 9.0 million | - | 604638 |
NEXI Shares Outstanding
NEXI Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | - | 647373 | 2.1 million | -2.1 billion |
| March 31, 2024 | - | 629111 | 2.0 million | - |
| Dec. 31, 2023 | 48.7 million | 1.2 million | -685213 | - |
| Sept. 30, 2023 | 981 | 6.0 million | 4.0 million | - |
NEXI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | - | 75408 |
| March 31, 2024 | - | 114912 |
| Dec. 31, 2023 | 2.1 million | 228509 |
| Sept. 30, 2023 | - | 265542 |
NEXI
Price: $0
52 week price:
Earnings Per Share: -18.51 USD
P/E Ratio: -0.01
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 424800
Market Capitalization: 139